Viewing Study NCT00416169


Ignite Creation Date: 2025-12-24 @ 10:51 PM
Ignite Modification Date: 2025-12-25 @ 8:20 PM
Study NCT ID: NCT00416169
Status: COMPLETED
Last Update Posted: 2011-06-08
First Post: 2006-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-05
Start Date Type: None
Primary Completion Date: None
Primary Completion Date Type: None
Completion Date: 2004-07
Completion Date Type: ACTUAL
First Submit Date: 2006-12-22
First Submit QC Date: None
Study First Post Date: 2006-12-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2011-06-06
Last Update Post Date: 2011-06-08
Last Update Post Date Type: ESTIMATED